Dr. Lüske initially studied Environmental Sciences at the Carl von Ossietzky University Oldenburg focusing on Marine Chemistry (Bachelor of Science). She performed her master’s degree in the field of “Toxicology“ at the Technical University of Kaiserslautern. During this study program, Dr. Lüske gained versatile insight into the pharmaceutical industry. This led her to the Immunotoxicology Department at the Bayer Health Care AG in Wuppertal for the conduct of her master’s thesis (Topic: Gene expression changes in rat lungs after inhalation of nanoparticles).

To perform her PhD at the University Medical Center Göttingen, she received a grant from the German Research Foundation. End of 2015 she completed her PhD in the field of “Molecular Medicine“, which shifted her focus to the field of Clinical Pharmacology, dealing with cancer research (Title: Molecular determinants for the outcome in gemcitabine-treated pancreatic cancer). The results of her PhD thesis were published in the prestigious Journal of the National Cancer Institute.

Afterwards, she continued to be employed as a research assistant at the University Medical Center Göttingen, for further research on pancreatic ductal adenocarcinoma.

Mrs. Lüske joined IPPMed in 2017, and has taken over the management in 2021.